Canada Pension Plan Investment Board
ABCL icon

Canada Pension Plan Investment Board’s AbCellera Biologics ABCL Stock Holding History

Canada Pension Plan Investment Board’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-31,293
Closed -$310K – 1161
2022
Q3 		$310K Sell
31,293
-362,483
-92% -$3.98M ﹤0.01% 1006
2022
Q2 		$4.19M Hold
393,776
– – 0.01% 561
2022
Q1 		$3.84M Sell
393,776
-41,624
-10% -$394K 0.01% 645
2021
Q4 		$6.23M Buy
+435,400
New +$6.61M 0.01% 667
2021
Q2 		– Sell
-125,000
Closed -$4.25M – 1140
2021
Q1 		$4.25M Buy
+125,000
New +$4.98M 0.01% 670

Other funds holding ABCL

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $4.26B AUM 5.81% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Canada Pension Plan Investment Board's ABCL Position: Q4 2022 in Review

Canada Pension Plan Investment Board sold out of AbCellera Biologics (ABCL) in Q4 2022, closing a stake of 31,293 shares — an estimated $310K sold.

Canada Pension Plan Investment Board first reported a position in ABCL in Q1 2021 and held it in 5 quarters. The position peaked at $6.23M in Q4 2021. 201 funds tracked by Wall St. Rank hold ABCL as of Q4 2022.

  • Canada Pension Plan Investment Board reported no remaining AbCellera Biologics position as of Q4 2022 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 31,293 AbCellera Biologics shares in Q4 2022, an estimated $310K.
  • Canada Pension Plan Investment Board first reported a position in AbCellera Biologics in Q1 2021 and held it in 5 quarters.
  • Canada Pension Plan Investment Board's AbCellera Biologics position peaked at $6.23M in Q4 2021.
  • 201 funds tracked by Wall St. Rank held AbCellera Biologics as of Q4 2022.

Based on Canada Pension Plan Investment Board's 13F filing for Q4 2022, filed 14 Feb 2023.